Systematic review on irrational use of medicines in China and Vietnam

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Mao, Wenhui ^a   Vu, Huyen ^c   Xie, Zening ^a   Chen, Wen ^a,b   Tang, Shenglan ^c  

^a FUDAN UNIVERSITY   (China)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE KUNSHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DRUG;

CHINA; COMPARATIVE STUDY; DRUG MISUSE; HUMAN; INAPPROPRIATE PRESCRIBING; POLYPHARMACY; REVIEW; RURAL AREA; SYSTEMATIC REVIEW; URBAN AREA; VIET NAM; META ANALYSIS; RISK FACTOR;

CHINA; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; VIETNAM;

EID: 84925679413     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117710     Document Type: Review

References (55)

1. Hogerzeil H (1995) Promoting rational drug use: an international perspective. Brit J Clin Pharmaco 39:1-6.
2. White TJ, Araekelian A, Rho JP (1999) Counting the costs of drug related adverse events. Pharmacoeconomics, 15(5):445-458. PMID: 10537962
3. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. Journal of the American Medical Association 279 (15):120-125.
4. Hitchen L (2006) Adverse drug reactions result in 250 000 UK admissions a year. Brit Med J 332:1109. PMID: 16690649
5. Pirmohamed M, James S, Meakin S, Green C, Scott AK, et al. (2004) Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18,820 patients. Brit Med J 329:15-19. PMID: 15231615
6. World Health Organization (2002) Promoting rational use of medicines: Core components. Available: http://archives.who.int/tbs/rational/h3011e.pdf.
7. World Health Organization (2009) Medicines use in primary care in developing and transitional countries: Fact book summarizing results from studies reported between 1990 and 2006. WHO Press.
8. World Health Organization (2011) The World Medicines Situation 2011-Rational Use of Medicines. WHO Press. doi: 10.1186/1475-2875-10-326 PMID: 22129872
9. World Health Organization (2012) The pursuit of responsible use of medicines: Sharing and learning from country experiences. WHO Press
10. Gummodoka B, Vos J, Berege ZA, van Asten HA, Dolmans WM, et al (1996) Injection practices in Mwanza region, Tanzania: prescription, patient demand and sterility. Trop Med Int Health 1(6):874-880. PMID: 8980604
11. Greenhalgh T (1987) Drug prescription and self-medication in India: an exploratory survey. Soc Sci Med, 25(3): 307-318. PMID: 3629304
12. Reeler AV, Hematorn C (1994) Injection practices in the third world. A case study of Thailand. WHO/ DAP/94.8.
13. van Staa A, Hardon A (1996) Injection practices in the developing world: A comparative review of field studies in Uganda and Indonesia. WHO/DAP/96.4.
14. World Health Organization (2001) How to investigate drug use in health facilities: Selected drug use indicators. Available: http://apps.who.int/medicinedocs/pdf/s2289e/s2289e.pdf.
15. Dong L, Yan H, Wang D (2008) Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China. J Antimicrob Chemother 62(2):410-415. doi: 10.1093/jac/dkn153 PMID: 18400805
16. Dong L, Yan H, Wang D (2011) Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract. 28(1):63-67. doi: 10.1093/fampra/cmq077 PMID: 20876222
17. Sun Q, Santoro MA, Meng Q, Liu C, Eggleston K (2008) Pharmaceutical policy in China. Health Affairs 27(4):1042-1050. doi: 10.1377/hlthaff.27.4.1042 PMID: 18607039
18. Larsson M, Krnovall G, Nguyen TKC, Karlsson I, Lager F, et al (2000) Antibiotic medication and bacteria resistance to antibiotics: a survey of children in a Vietnam community. Trop Med Int Health 5:711-721. PMID: 11044266
19. Lonnroth K, Thuong LM, Linh PD, Diwan V (1998) Risks and benefits of private health care: Exploring physicians' view on private health care in Ho Chi Minh City, Vietnam. Health Policy 45:81-97. PMID: 10186226
20. Larsson M (1999) Antibiotic use and resistance: Assessing and improving utilization and provision of antibiotics and other drugs in Vietnam. PhD Thesis. Department of Public Health Science, Karolinska Institute.1999.
21. Nguyen TKC (2002) Towards good pharmacy practice in Hanoi: A multi-intervention study in private sector. PhD Thesis. Department of Public Health Sciences, Karolinska Institute.
22. Dang H, Nguyen P, Bales S, Chen J, Henry L, et al. (2007) Rural health care in Vietnam and China: Conflict between market reforms and social need. Int J Health Serv, 37(3):555-572. PMID: 17844934
23. Vietnam's Ministry of Health (2004) National Health Accounts-The Process of implementation and development in Vietnam. Statistical Publishing House.
24. China National Health Economics Institute (2012) China national health accounts report 2012. Beijing: Ministry of Health.
25. Tang S, Sun J, Qu G, ChenW(2007) Pharmaceutical policies in China: Issues and problems. WHO Beijing Office, Available: http://archives.who.int/tbs/ChinesePharmaceuticalPolicy/ BackgroundENGdefault.htm
26. Yip W, HsiaoW(2009) China's health care reform: A tentative assessment. China Economic Review 20:613-619.
27. State Planning Commission (1996) Interim Measures for Drug Price. Available: http://www.law-lib.com/ law/law-view.asp?id=12681
28. State Planning Commission (1997) Supplementary Regulations of Interim Measures for Drug Price. Available: http://china.findlaw.cn/fagui/p-1/191310.html.
29. State Planning Commission (1998) State Planning Commission's Notice on Improving Drug Price Policies to Improve the Management of Drug Prices. Available: http://www.110.com/fagui/law-28796.html.
30. Center for Health Statistics and Information, Ministry of Health (2013) China Health and Family Planning Statistical Yearbook 2013. Available: http://www.nhfpc.gov.cn/zwgkzt/tjnj/list.shtml.
31. Dong H, Bogg L, Rehnberg C, Diwan V (1999) Health financing policies: Providers' opinions and prescribing behavior in rural China. Int J Technol Assess. 15(4):686-698. PMID: 10645110
32. Chuc NT, Larsson M, Falkenberg T, Do NT, Binh NT, et al. (2001) Management of childhood acute respiratory infections at private pharmacies in Vietnam. Ann Pharmacother, 35(10):1283-1288. PMID: 11675861
33. Michanek E, Valdelin J, Persson H, Que TT, Simonsson B (1992) Doi moi and health. SIDA Evaluation Report, Stockhom
34. Chuc NTK, Tomson G (1999) "Doi moi" and private pharmacies: a case study on dispensing and financial issues in Hanoi, Vietnam. Eur J Clin Pharmacol, 55(4):325-332. PMID: 10424327
35. Vietnam's Ministry of Health (2011) Draft of National Strategy on Health Protection, Care and Improvement for Population 2011-2020, and a Vision to 2030. Hanoi.
36. Vietnam's Ministry of Health and WHO (2010) National Health Accounts Implemented in Vietnam in the period 1998-2008. Hanoi: Statistical Publishing House.
37. Lieu DH (2005) Health financing from household and user perspective. Hanoi: Medical Publishing House.
38. Ministry of Health (1996) Strategic Orientation for People's Health Care and Protection in the Period of 1996-2000 and Vietnam's National Drug Policy. Hanoi, Vietnam. Available: http://thuvienphapluat.vn/ archive/Nghi-quyet-37-CP-dinh-huong-cong-tac-cham-soc-va-bao-ve-suc-khoe-nhan-dan-trong-thoi-gian-1996-2000-va-chinh-sach-quoc-gia-ve-thuoc-Viet-Nam-vb39784.aspx.
39. Vietnam's Ministry of Health (2003) 1847/2003/QD-BYT Regulation of drug prescribing and selling pre-scription-only (in Vietnamese). Vietnam.
40. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6):e1000097. doi: 10. 1371/journal.pmed.1000097 PMID: 19621072
41. Critical Appraisal Skills Programme, Making sense of evidence (2013) Available: http://www.casp-uk. net/#!casp-tools-checklists/c18f8.
42. World Health Organization (1993) How to investigate drug use in health facilities selected drug use indi-cators-EDM research series No.007.
43. National Health and Family Planning Commission of People's Republic of China (2012). China Health Statistics Yearbook 2012.
44. Hoa NQ, Trung NV, Larsson M, Eriksson B, Phuc HD, et al. (2010). Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study. BMC Infect Dis, 10(1):85.
45. Li Y, Xu J, Wang F, Wang B, Liu L, et al. (2012) Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Affairs, 31(5):1075-1082. doi: 10.1377/hlthaff.2010.0965 PMID: 22566449
46. Mao W, Tang S, ChenW(2013) Does perverse economic incentive lead to the irrational uses of medicines? Expert Rev Pharm Out, 13(6):693-696.
47. Kaljee LM, Anh DD, Minh TT, Tho LH, Batmunkh N, et al. (2011) Rural and urban Vietnamese mothers utilization of healthcare resources for children under 6 years with pneumonia and associated symptoms. Journal of Behavioral Medicine, 34(4): 254-267. doi: 10.1007/s10865-010-9305-5 PMID: 21127959
48. Han S, Liang H, Su W, Xue Y, Shi L (2013) Can Price controls reduce pharmaceutical expenses? A case study of antibacterial expenditures in 12 Chinese hospitals from 1996 to 2005. Int J Health Serv, 43(1):91-103. PMID: 23527456
49. Luo J (2009) Study on the status and influential factors of self-medication with antibacterial agents among customers in pharmacies. PhD Thesis. Central South University.
50. Hoa NQ, Öhman A, Lundborg CS, Chuc NTK (2007) Drug use and health-seeking behavior for childhood illness in Vietnam-a qualitative study. Health policy, 82(3):320-329. PMID: 17118482
51. Hoan LT, Chuc NTK, Ottosson E, Allebeck P (2009) Drug use among children under 5 with respiratory illness and/or diarrhoea in a rural district of Vietnam. Pharmacoepidem Dr S, 18(6):448-453.
52. World Health Organization (2004) Equitable access to essential medicines: a framework for collective action. Geneva
53. Vietnam National Assembly (2005) Law of Pharmacy No. 34/2005/QH11 issued on June 1th
54. Chen M, Wang L, Chen W, Zhang L, Jiang H, et al. (2014). Does Economic Incentive Matter for Rational Use of Medicine? China's Experience from the Essential Medicines Program. Pharmacoeconomics, 32(3):245-255. doi: 10.1007/s40273-013-0068-z PMID: 23813440
55. Reynolds L, McKee M (2011) Serve the people or close the sale? Profit-driven overuse of injections and infusions in China's market-based healthcare system. Int J Health Plann Manage, 26(4):449-70. doi: 10.1002/hpm.1112 PMID: 22213261